Почетна › Гојазност › Arizona › Tucson
Kliničke studije za Гојазност u gradu Tucson, AZ
20 studija za Гојазност traži učesnike na lokacijama u gradu Tucson i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Тражи се учесникФаза 3
- Arizona Clinical Trials, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Тражи се учесникФаза 3
- Arizona Clinical Trials, Tucson
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Тражи се учесникФаза 3
- Tucson Clinical Research Institute, Tucson
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Тражи се учесникФаза 3
- University of Arizona, Tucson
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Тражи се учесникФаза 3
- Tucson Clinical Research Institute, Tucson
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Тражи се учесникФаза 3
- Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Тражи се учесникФаза 3
- Tucson Orthopaedic Institute - North Wyatt Drive, Tucson
A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
Тражи се учесникФаза 3
- Noble Clinical Research, LLC, Tucson
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Тражи се учесникФаза 3
- University of Arizona, Tucson
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Тражи се учесникФаза 2
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Тражи се учесникФаза 3
- Pima Heart and Vascular Clinical Research, Tucson
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Тражи се учесникФаза 3
- Research Site, Tucson
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Тражи се учесникФаза 2
- Arizona Clinical Trials /ID# 282372, Tucson
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Тражи се учесникФаза 3Здраве особе су добродошле
- ACCOMPLISH-2 Research Site, Tucson
The RESET System Pivotal Clinical Trial (Protocol Revision K)
Тражи се учесник
- M3 Wake Research, Tucson
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Тражи се учесникФаза 2
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Тражи се учесникФаза 2
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Тражи се учесникФаза 3
- AURORA-2 Clinical Site, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Тражи се учесникФаза 3
- AURORA-1 Clinical Site, Tucson
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Тражи се учесникФаза 3
- ACCOMPLISH-1 Research Site, Tucson
Studije za Гојазност u drugim gradovima
- Houston, TX44 студија
- Chicago, IL40 студија
- New York City, NY39 студија
- San Antonio, TX39 студија
- Washington, DC34 студија
- Dallas, TX33 студија
- Orlando, FL33 студија
- Miami, FL28 студија
- Boston, MA26 студија
- Atlanta, GA26 студија
- Los Angeles, CA25 студија
- St. Louis, MO25 студија
Ostale studije u gradu Tucson
- Рак дојке18 студија
- Немалоклетни карцином плућа18 студија
- Гојазност17 студија
- Метастатски карцином14 студија
- Dijabetes tipa 213 студија
- Рак (све врсте)12 студија
- Рак простате12 студија
- Колоректални карцином11 студија
- Кардиоваскуларне болести11 студија
- Steatotna bolest jetre10 студија
- Akutna mijeloidna leukemija10 студија
- Висок крвни притисак10 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.